从实验室到资本市场：陕股交与西交大联手搭建科创“直通车”

Core Insights - The collaboration between Shaanxi Equity Exchange and Xi'an Jiaotong University aims to address the funding challenges faced by early-stage technology companies, exemplified by the successful seed round financing of Xian Cold Electric Technology Co., Ltd. [1][2] Group 1: Funding Challenges - The transformation of scientific achievements into marketable products faces significant funding difficulties, with early-stage tech companies experiencing "financing difficulties and high costs" amid tightening IPOs and limited exit channels [2][5] - Despite national policies promoting technology funding, many startups find it challenging to access these resources effectively [2][5] Group 2: Innovation and Support Systems - The establishment of the Western Innovation Port Zone provides a tailored service area for technology transfer companies, facilitating a "fast track" from laboratory to capital market [3][4] - The zone's core services include brand promotion, equity management, financing intelligence, and regulatory support, addressing various operational challenges faced by startups [3][4] Group 3: Specialized Services - Four specialized services have been introduced to support early-stage projects: - "University Angel Investment" to assist in equity financing for university projects [4] - "Service + Equity Rights" to allow early-stage companies to obtain services at low costs while securing equity rights [4] - "Angel Station" to connect investment institutions with promising university projects [4] - A dedicated team providing comprehensive support from incubation to growth [4] Group 4: Case Study of Cold Electric Technology - Cold Electric Technology, a high-tech company focused on medical applications, faced challenges due to limited market recognition and funding constraints [5][6] - The company successfully engaged with the Shaanxi Equity Exchange for financing, leading to a tailored service plan that included governance standardization and business model optimization [6][7] - The company secured millions in seed funding, which will be used for product development and market expansion, and is now positioned for further growth in the pet and human medical markets [7][8]